No Data
Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation
Citi Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $15
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
Companies Like Cogent Biosciences (NASDAQ:COGT) Are In A Position To Invest In Growth
Express News | Baird Maintains Neutral on Cogent Biosciences, Raises Price Target to $10
Cogent Biosciences, Inc. (COGT): This Small-Cap Healthcare Stock Is A Good Buy Right Now